Phase II study of adjuvant chemotherapy with pemetrexed and cisplatin with a short hydration method for completely resected nonsquamous non‐small cell lung cancer

BACKGROUND: Cisplatin (CDDP) and vinorelbine as an adjuvant chemotherapy improve the overall survival of patients with completely resected non‐small cell lung cancer (NSCLC). However, the treatment completion rate is low due to severe adverse events (AEs). Pemetrexed (PEM) has been used in advanced...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Thorac Cancer
Autori principali: Tachihara, Motoko, Dokuni, Ryota, Okuno, Keiko, Tokunaga, Shuntaro, Nakata, Kyosuke, Katsurada, Naoko, Yamamoto, Masatsugu, Nagano, Tatsuya, Kobayashi, Kazuyuki, Tanaka, Yugo, Funada, Yasuhiro, Maniwa, Yoshimasa, Nishimura, Yoshihiro
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons Australia, Ltd 2020
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7471012/
https://ncbi.nlm.nih.gov/pubmed/32729237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13567
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi